These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22277939)

  • 1. Priming of Leishmania-reactive CD8+ T cells in vivo does not require LMP7-containing immunoproteasomes.
    Brosch S; Tenzer S; Akkad N; Lorenz B; Schild H; von Stebut E
    J Invest Dermatol; 2012 Apr; 132(4):1302-5. PubMed ID: 22277939
    [No Abstract]   [Full Text] [Related]  

  • 2. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
    Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
    J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Regulatory T Cells in Leishmania major‒Infected BALB/c Mice Does Not Require Langerin+ Dendritic Cells.
    Lukas D; Dietze-Schwonberg K; Kautz-Neu K; Lorenz B; Yogev N; Clausen BE; von Stebut E
    J Invest Dermatol; 2021 Apr; 141(4):936-938. PubMed ID: 32941919
    [No Abstract]   [Full Text] [Related]  

  • 5. Skin dendritic cells in murine cutaneous leishmaniasis.
    Udey MC; von Stebut E; Mendez S; Sacks DL; Belkaid Y
    Immunobiology; 2001 Dec; 204(5):590-4. PubMed ID: 11846222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis.
    Fritzsche C; Schleicher U; Bogdan C
    Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective and long-lasting immunity against the parasite Leishmania major in CD8-deficient mice.
    Huber M; Timms E; Mak TW; Röllinghoff M; Lohoff M
    Infect Immun; 1998 Aug; 66(8):3968-70. PubMed ID: 9673288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
    Erb K; Blank C; Ritter U; Bluethmann H; Moll H
    Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In cutaneous leishmaniasis, induction of retinoic acid in skin-derived Langerhans cells is not sufficient for induction of parasite persistence-mediating regulatory T cells.
    Dietze-Schwonberg K; Kautz-Neu K; Lorenz B; Clausen BE; von Stebut E
    J Dermatol Sci; 2017 Sep; 87(3):307-309. PubMed ID: 28823643
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major.
    Gaafar A; Veress B; Permin H; Kharazmi A; Theander TG; el Hassan AM
    Clin Immunol; 1999 Jun; 91(3):314-20. PubMed ID: 10370377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major.
    Akbari M; Honma K; Kimura D; Miyakoda M; Kimura K; Matsuyama T; Yui K
    J Immunol; 2014 Mar; 192(5):2271-9. PubMed ID: 24489086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.
    Wershil BK; Theodos CM; Galli SJ; Titus RG
    J Immunol; 1994 May; 152(9):4563-71. PubMed ID: 8157970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection.
    Matsushita M; Freigang S; Schneider C; Conrad M; Bornkamm GW; Kopf M
    J Exp Med; 2015 Apr; 212(4):555-68. PubMed ID: 25824823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology. Neutrophil soldiers or Trojan Horses?
    John B; Hunter CA
    Science; 2008 Aug; 321(5891):917-8. PubMed ID: 18703727
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.
    Herath S; Kropf P; Müller I
    Parasite Immunol; 2003; 25(11-12):559-67. PubMed ID: 15053777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mannose receptor during experimental leishmaniasis.
    Akilov OE; Kasuboski RE; Carter CR; McDowell MA
    J Leukoc Biol; 2007 May; 81(5):1188-96. PubMed ID: 17261547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.